These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24036493)

  • 1. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
    Rizzo WB
    Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fatty aldehyde dehydrogenase in epidermal structure and function.
    Rizzo WB
    Dermatoendocrinol; 2011 Apr; 3(2):91-9. PubMed ID: 21695018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
    Rizzo WB; S'Aulis D; Jennings MA; Crumrine DA; Williams ML; Elias PM
    Arch Dermatol Res; 2010 Aug; 302(6):443-51. PubMed ID: 20049467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
    Rizzo WB; Heinz E; Simon M; Craft DA
    Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.
    S'aulis D; Khoury EA; Zabel M; Rizzo WB
    Mol Genet Metab; 2020; 131(1-2):253-258. PubMed ID: 32800643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjogren-Larsson syndrome associated hypermelanosis.
    Xu YC; Hou JQ; Zhu WJ; Li P
    J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.
    Naganuma T; Takagi S; Kanetake T; Kitamura T; Hattori S; Miyakawa T; Sassa T; Kihara A
    J Biol Chem; 2016 May; 291(22):11676-88. PubMed ID: 27053112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
    Malheiro AR; da Silva TF; Brites P
    J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.
    Staps P; Rizzo WB; Vaz FM; Bugiani M; Giera M; Heijs B; van Kampen AHC; Pras-Raves ML; Breur M; Groen A; Ferdinandusse S; van der Graaf M; Van Goethem G; Lammens M; Wevers RA; Willemsen MAAP
    J Inherit Metab Dis; 2020 Nov; 43(6):1265-1278. PubMed ID: 32557630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
    Rizzo WB; Lin Z; Carney G
    Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren-Larsson syndrome.
    Rizzo WB
    Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.
    Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB
    J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
    Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
    FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.